Nidhogg Resources Holding (formerly known as Eurocine Vaccines) is a clinical-stage company that specializes in vaccine development. It provides a technology named Endocine that is based on endogenous lipids naturally found ubiquitously in the human body. The technology can be applied to vaccine antigens to enable stimulation of immunity using whole or split antigens, proteins, or peptides.